New and emerging therapies for diabetic kidney disease

被引：0
|
作者：
Ricardo Correa-Rotter
Louise J. Maple-Brown
Rakesh Sahay
Katherine R. Tuttle
Ifeoma I. Ulasi
机构：
[1] Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán,Menzies School of Health Research
[2] Universidad Nacional Autónoma de México,Department of Endocrinology
[3] Charles Darwin University,Providence Medical Research Center
[4] Royal Darwin and Palmerston Hospitals,Kidney Research Institute and Institute of Translational Health Sciences
[5] NT Health,Department of Medicine, College of Medicine
[6] Osmania Medical College,Renal Unit, Department of Medicine
[7] Providence Inland Northwest Health,Renal Unit, Department of Internal Medicine
[8] University of Washington,undefined
[9] University of Nigeria,undefined
[10] Ituku-Ozalla,undefined
[11] University of Nigeria Teaching Hospital,undefined
[12] Ituku-Ozalla,undefined
[13] Alex Ekwueme Federal University Teaching Hospital,undefined
来源：
Nature Reviews Nephrology | 2024年 / 20卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The theme of World Kidney Day 2024 is “kidney health for all — advancing equitable access to care and optimal medication practice”. To mark this event, Nature Reviews Nephrology invited five researchers from different geographical regions worldwide to discuss the impact of new and emerging therapies for diabetic kidney disease on patient care as well as the barriers that must be overcome to ensure equitable access to these therapies.
引用
收藏
页码：156 / 160
页数：4
相关论文
共 50 条
  • [21] Antihyperglycemic agents as novel natriuretic therapies in diabetic kidney disease
    Leon Jimenez, David
    Cherney, David Z. I.
    Bjornstad, Petter
    Castilla Guerra, Luis
    Miramontes Gonzalez, Jose Pablo
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2018, 315 (05) : F1406 - F1415
  • [22] ROLE OF INCRETIN BASED THERAPIES IN THE TREATMENT OF DIABETIC KIDNEY DISEASE
    Fioretto, Paola
    Frascati, Andrea
    DIABETES MELLITUS, 2018, 21 (05): : 395 - 398
  • [23] New Diabetes Therapies and Diabetic Kidney Disease Progression: the Role of SGLT-2 Inhibitors
    Dekkers, Claire C. J.
    Gansevoort, Ron T.
    Heerspink, Hiddo J. L.
    CURRENT DIABETES REPORTS, 2018, 18 (05)
  • [24] New Diabetes Therapies and Diabetic Kidney Disease Progression: the Role of SGLT-2 Inhibitors
    Claire C. J. Dekkers
    Ron T. Gansevoort
    Hiddo J. L. Heerspink
    Current Diabetes Reports, 2018, 18
  • [25] Cell Therapies in Diabetic Kidney Disease: Is It Time for Clinical Translation?
    Chen, Jun-Zhang
    Liang, Bo
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2023, 34 (12): : 2051 - 2052
  • [26] The Effects of Glucose-Lowering Therapies on Diabetic Kidney Disease
    Agrawal, V.
    Giri, C.
    Solomon, R. J.
    CURRENT DIABETES REVIEWS, 2015, 11 (03) : 191 - 200
  • [27] A New Chapter for Diabetic Kidney Disease
    de Boer, Ian H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (09): : 885 - 887
  • [28] New and emerging medical therapies in Parkinson's disease
    Lotia, Mitesh
    Jankovic, Joseph
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (07) : 895 - 909
  • [29] New and emerging drug therapies for Cushing's disease
    Stoermann, Sylvere
    Schopohl, Jochen
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (11) : 1187 - 1200
  • [30] New and emerging disease modifying therapies for multiple sclerosis
    Saidha, Shiv
    Eckstein, Christopher
    Calabresi, Peter A.
    YEAR IN IMMUNOLOGY, 2012, 1247 : 117 - 137
12345